April 16, 2013 — RaySearch Laboratories AB (publ.) has entered into a license agreement with GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt, Germany regarding techniques for calculating radiobiological effective dose in ion beam treatments.

Ion beam therapy is the most advanced form of external radiotherapy where the tumor is irradiated with protons or carbon ions. Compared to conventional radiotherapy, where the tumor is irradiated with photons, the energy deposition of the ion beams can be controlled much more effectively. This means that the radiation dose can be delivered even more precisely and as a result, the unwanted dose to healthy tissues can be reduced, leading to a reduction of treatment-related side effects. However, the biological effect of ions on tissue is different compared to traditional photon beams and this difference must be accounted for during treatment planning for ion beams.

The Biological Modeling research team at GSI, led by Dr. Michael Scholz, has for a long time developed and refined the so-called Local Effect Model (LEM) for calculating the relative biological effectiveness during irradiation with therapeutic carbon ion beams. In the LEM model the survival of cells irradiated with ion beams is predicted based on their response to photons. In the 90s the group at GSI pioneered the optimization of radiobiological dose within the framework of the LEM model. The technique is now well established in the field of carbon beam therapy and was in clinical use at GSI for a decade (1997 to 2008) and is currently used at the carbon therapy centers HIT in Heidelberg, Germany, and at CNAO in Pavia, Italy, and soon also at the Shanghai Proton and Heavy Ion Hospital in Shanghai, China.

The new agreement, licensed through the Patent and Technology Transfer department at GSI, gives RaySearch the right to integrate algorithms and know-how from GSI related to the LEM in RaySearch’s RayStation treatment planning system. The LEM and RaySearch’s algorithms for dose calculation will be built into the system’s module for carbon treatment plan optimization.

“We are happy to have RaySearch as a strong partner in the field of therapy planning systems, and we are confident that this assures continuous support of ion beam therapy centers with state-of-the-art biophysical modelling for treatment plan optimization. We also hope that this represents the starting point for a long-term cooperation that will help to facilitate the translation from cutting edge research to clinical applications”, says Michael Scholz, Head of the Biological Modelling research group at GSI.

For more information: visit www.raysearchlabs.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now